120 related articles for article (PubMed ID: 28818808)
21. γ-Catenin-Dependent Signals Maintain BCR-ABL1
Luong-Gardiol N; Siddiqui I; Pizzitola I; Jeevan-Raj B; Charmoy M; Huang Y; Irmisch A; Curtet S; Angelov GS; Danilo M; Juilland M; Bornhauser B; Thome M; Hantschel O; Chalandon Y; Cazzaniga G; Bourquin JP; Huelsken J; Held W
Cancer Cell; 2019 Apr; 35(4):649-663.e10. PubMed ID: 30991025
[TBL] [Abstract][Full Text] [Related]
22. Detection of Pathogenic Isoforms of
Zhao W; Li Y; Yao C; Zhang G; Zhao KY; Chen W; Ru P; Pan X; Tu H; Jones D
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33126432
[TBL] [Abstract][Full Text] [Related]
23. Poor responses to tyrosine kinase inhibitors in a child with precursor B-cell acute lymphoblastic leukemia with SNX2-ABL1 chimeric transcript.
Masuzawa A; Kiyotani C; Osumi T; Shioda Y; Iijima K; Tomita O; Nakabayashi K; Oboki K; Yasuda K; Sakamoto H; Ichikawa H; Hata K; Yoshida T; Matsumoto K; Kiyokawa N; Mori T
Eur J Haematol; 2014 Mar; 92(3):263-7. PubMed ID: 24215620
[TBL] [Abstract][Full Text] [Related]
24. ERG and c-MYC regulate a critical gene network in BCR::ABL1-driven B cell acute lymphoblastic leukemia.
Behrens K; Brajanovski N; Xu Z; Viney EM; DiRago L; Hediyeh-Zadeh S; Davis MJ; Pearson RB; Sanij E; Alexander WS; Ng AP
Sci Adv; 2024 Mar; 10(10):eadj8803. PubMed ID: 38457494
[TBL] [Abstract][Full Text] [Related]
25. [Effects of PCI-32765 and Dasatinib on the Acute Lymphoblastic Leukemic Cells and Their Mechanisms].
Deng Y; Tao SD; Zhang X; Ma JJ; He ZM; Chen Y; Deng ZK; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):72-79. PubMed ID: 28245378
[TBL] [Abstract][Full Text] [Related]
26. BCR-ABL1-like acute lymphoblastic leukaemia: From bench to bedside.
Boer JM; den Boer ML
Eur J Cancer; 2017 Sep; 82():203-218. PubMed ID: 28709134
[TBL] [Abstract][Full Text] [Related]
27. Comparative study of DNA damage, cell cycle and apoptosis in human K562 and CCRF-CEM leukemia cells: role of BCR/ABL in therapeutic resistance.
Pytel D; Wysocki T; Majsterek I
Comp Biochem Physiol C Toxicol Pharmacol; 2006 Sep; 144(1):85-92. PubMed ID: 16904383
[TBL] [Abstract][Full Text] [Related]
28. Combination of ponatinib with Hedgehog antagonist vismodegib for therapy-resistant BCR-ABL1-positive leukemia.
Katagiri S; Tauchi T; Okabe S; Minami Y; Kimura S; Maekawa T; Naoe T; Ohyashiki K
Clin Cancer Res; 2013 Mar; 19(6):1422-32. PubMed ID: 23319824
[TBL] [Abstract][Full Text] [Related]
29. ABL1 gene deletion without BCR/ABL1 rearrangement in a young adolescent with precursor B-cell acute lymphoblastic leukemia: clinical study and literature review.
Kim MJ; Yoon HS; Lim G; Kim SY; Lee HJ; Suh JT; Lee J; Lee WI; Park TS
Cancer Genet Cytogenet; 2010 Jan; 196(2):184-8. PubMed ID: 20082857
[TBL] [Abstract][Full Text] [Related]
30. Reprogramming of primary human Philadelphia chromosome-positive B cell acute lymphoblastic leukemia cells into nonleukemic macrophages.
McClellan JS; Dove C; Gentles AJ; Ryan CE; Majeti R
Proc Natl Acad Sci U S A; 2015 Mar; 112(13):4074-9. PubMed ID: 25775523
[TBL] [Abstract][Full Text] [Related]
31. BCR-ABL1-like B-Lymphoblastic Leukemia/Lymphoma with FOXP1-ABL1 Rearrangement: Comprehensive Laboratory Identification Allowing Tyrosine Kinase Inhibitor Use.
Yenamandra AK; Kaviany S; Borinstein SC; Friedman DL; Kovach AE
Lab Med; 2019 Oct; 50(4):401-405. PubMed ID: 30938769
[TBL] [Abstract][Full Text] [Related]
32. [Mutations in the BCR-ABL1 gene in a peruvian patient with acute lymphoblastic leukemia resistant to therapy].
Ortiz CA; Alvarez YP; Dongo-Pflucker KL; Valdivia E; Mendoza Fernández J; Dávila S; Mora-Alférez P
Rev Fac Cien Med Univ Nac Cordoba; 2017; 74(2):162-166. PubMed ID: 28657534
[TBL] [Abstract][Full Text] [Related]
33. Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1
Schjerven H; Ayongaba EF; Aghajanirefah A; McLaughlin J; Cheng D; Geng H; Boyd JR; Eggesbø LM; Lindeman I; Heath JL; Park E; Witte ON; Smale ST; Frietze S; Müschen M
J Exp Med; 2017 Mar; 214(3):793-814. PubMed ID: 28190001
[TBL] [Abstract][Full Text] [Related]
34. Ribozyme-mediated inhibition of a Philadelphia chromosome-positive acute lymphoblastic leukemia cell line expressing the p190 bcr-abl oncogene.
Snyder DS; Wu Y; McMahon R; Yu L; Rossi JJ; Forman SJ
Biol Blood Marrow Transplant; 1997 Oct; 3(4):179-86. PubMed ID: 9360779
[TBL] [Abstract][Full Text] [Related]
35. Acute lymphoblastic leukaemia with an e1a3 BCR-ABL1 fusion.
Langabeer SE; Haslam K; Kelly J; Leahy M; Vandenberghe E
Acta Haematol; 2011; 126(4):214-5. PubMed ID: 21934295
[No Abstract] [Full Text] [Related]
36. The study of resistant mechanisms and reversal in an imatinib resistant Ph+ acute lymphoblastic leukemia cell line.
Xing H; Yang X; Liu T; Lin J; Chen X; Gong Y
Leuk Res; 2012 Apr; 36(4):509-13. PubMed ID: 22285507
[TBL] [Abstract][Full Text] [Related]
37. Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia.
Castor A; Nilsson L; Astrand-Grundström I; Buitenhuis M; Ramirez C; Anderson K; Strömbeck B; Garwicz S; Békássy AN; Schmiegelow K; Lausen B; Hokland P; Lehmann S; Juliusson G; Johansson B; Jacobsen SE
Nat Med; 2005 Jun; 11(6):630-7. PubMed ID: 15908956
[TBL] [Abstract][Full Text] [Related]
38. Discovery and characterization of a novel potent type II native and mutant BCR-ABL inhibitor (CHMFL-074) for Chronic Myeloid Leukemia (CML).
Liu F; Wang B; Wang Q; Qi Z; Chen C; Kong LL; Chen JY; Liu X; Wang A; Hu C; Wang W; Wang H; Wu F; Ruan Y; Qi S; Liu J; Zou F; Hu Z; Wang W; Wang L; Zhang S; Yun CH; Zhai Z; Liu J; Liu Q
Oncotarget; 2016 Jul; 7(29):45562-45574. PubMed ID: 27322145
[TBL] [Abstract][Full Text] [Related]
39. Acute monocytic leukemia with coexpression of minor BCR-ABL1 and PICALM-MLLT10 fusion genes along with overexpression of HOXA9.
Sindt A; Deau B; Brahim W; Staal A; Visanica S; Villarese P; Rault JP; Macintyre E; Delabesse E
Genes Chromosomes Cancer; 2006 Jun; 45(6):575-82. PubMed ID: 16518848
[TBL] [Abstract][Full Text] [Related]
40. CD66c expression in B-cell acute lymphoblastic leukemia: strength and weakness.
Guillaume N; Penther D; Vaida I; Gruson B; Harrivel V; Claisse JF; Capiod JC; Lefrere JJ; Damaj G
Int J Lab Hematol; 2011 Feb; 33(1):92-6. PubMed ID: 20666852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
